Cargando…

Biomimetic doxorubicin/ginsenoside co-loading nanosystem for chemoimmunotherapy of acute myeloid leukemia

BACKGROUND: Acute myeloid leukemia (AML) showed limited clinical therapeutic efficiency with chemotherapy for its multi-distributed lesions and hard-to-kill leukemia cells deep in the bone marrow. RESULTS: Here, a biomimetic nanosystem (DR@PLip) based on platelet membrane (PM) coating and doxorubici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mo, Qiao, Yingyu, Cao, Jie, Ta, La, Ci, Tianyuan, Ke, Xue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195256/ https://www.ncbi.nlm.nih.gov/pubmed/35701846 http://dx.doi.org/10.1186/s12951-022-01491-w

Ejemplares similares

Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy
por: Huang, Xiaoxian, et al.
Publicado: (2022)

Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model
por: Dong, Hang, et al.
Publicado: (2023)

Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy
por: Wang, Meng, et al.
Publicado: (2022)

A dual-responsive doxorubicin–indoximod conjugate for programmed chemoimmunotherapy
por: Yang, Zhaoxuan, et al.
Publicado: (2022)

Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles
por: Da Silva, Candido G., et al.
Publicado: (2019)

Novel synthesizing method of pH-dependent doxorubicin-loaded anti-CD22-labelled drug delivery nanosystem
por: Sun, Mengjiao, et al.
Publicado: (2015)

Inflammation and Microbiota Regulation Potentiate Pneumonia Therapy by Biomimetic Bacteria and Macrophage Membrane Nanosystem
por: Li, Yuan, et al.
Publicado: (2023)

Anti-cancer effects of ginsenoside CK on acute myeloid leukemia in vitro and in vivo
por: Hou, Yuzhu, et al.
Publicado: (2022)

GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy
por: Hu, Danrong, et al.
Publicado: (2016)

Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer
por: Bouzo, Belén L., et al.
Publicado: (2021)

DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
por: Tsagiopoulou, Maria, et al.
Publicado: (2019)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells
por: Chen, Yan, et al.
Publicado: (2013)

Lipid Nanosystems and Serum Protein as Biomimetic Interfaces: Predicting the Biodistribution of a Caffeic Acid-Based Antioxidant
por: Fernandes, Eduarda, et al.
Publicado: (2021)

Biomimetic ZIF8 Nanosystem With Tumor Hypoxia Relief Ability to Enhance Chemo-Photothermal Synergistic Therapy
por: Zhao, Ziming, et al.
Publicado: (2022)

Biomimetic Nanosystems for the Synergistic Delivery of miR-144/451a for Oral Squamous Cell Carcinoma
por: Li, Kunshan, et al.
Publicado: (2022)

Survival of patients with chronic lymphocytic leukemia before and after the introduction of chemoimmunotherapy in Germany
por: Kajüter, Hiltraud, et al.
Publicado: (2021)

Gold Nanosystems Covered with Doxorubicin/DNA Complexes: A Therapeutic Target for Prostate and Liver Cancer
por: Giráldez-Pérez, Rosa M., et al.
Publicado: (2022)

Treatment outcome of doxorubicin versus idarubicin in adult acute myeloid leukemia
por: Sherif, Hemat Afifi, et al.
Publicado: (2021)

Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer
por: Wang, Zhicheng, et al.
Publicado: (2021)

What Influences the Choice of Ibrutinib–Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia?
por: Bravaccini, Sara, et al.
Publicado: (2020)

Chemoimmunotherapy Administration Protocol Design for the Treatment of Leukemia through Mathematical Modeling and In Silico Experimentation
por: Valle, Paul A., et al.
Publicado: (2022)

Ultrasound Combined with Core Cross-Linked Nanosystem for Enhancing Penetration of Doxorubicin Prodrug/Beta-Lapachone into Tumors
por: Li, Qianyan, et al.
Publicado: (2020)

Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2
por: Popov, Alexander, et al.
Publicado: (2022)

Immunomodulatory Nanosystems
por: Feng, Xiangru, et al.
Publicado: (2019)

Neuronal mitochondria-targeted therapy for Alzheimer’s disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems
por: Han, Yang, et al.
Publicado: (2020)

CRPC Membrane-Camouflaged, Biomimetic Nanosystem for Overcoming Castration-Resistant Prostate Cancer by Cellular Vehicle-Aided Tumor Targeting
por: Lu, Kai, et al.
Publicado: (2022)

Targeting of the leukemia microenvironment by c(RGDfV) overcomes the resistance to chemotherapy in acute myeloid leukemia in biomimetic polystyrene scaffolds
por: Shen, Zhao-Hua, et al.
Publicado: (2016)

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy
por: Porrazzo, Marika, et al.
Publicado: (2020)

Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells
por: KIM, SUNG SU, et al.
Publicado: (2014)

MAPK signaling regulates the efficacy of chemoimmunotherapy
por: Ghiringhelli, François
Publicado: (2022)

Combination of coumarin and doxorubicin induces drug-resistant acute myeloid leukemia cell death
por: Al-Abbas, Nouf S., et al.
Publicado: (2021)

Molecular engineering of nanosystems
por: Rietman, Edward A
Publicado: (2001)

Thermal Nanosystems and Nanomaterials
por: Volz, Sebastian
Publicado: (2009)

Organic–inorganic nanosystems
por: Ziemann, Paul
Publicado: (2011)

Clinicopathological analysis of primary refractory diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy
por: Suzuki, Tomotaka, et al.
Publicado: (2021)

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia
por: Kay, Neil E., et al.
Publicado: (2016)

Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer
por: Zhao, Yongmei, et al.
Publicado: (2022)

Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA
por: Zhao, Jingtong, et al.
Publicado: (2023)

Dendritic Cell-Derived Exosomes Driven Drug Co-Delivery Biomimetic Nanosystem for Effective Combination of Malignant Melanoma Immunotherapy and Gene Therapy
por: Lin, Jiecheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e9ajqnpg3g2tfsss83ll9rle8q